Activity Overview
Please read the following information about this continuing pharmacy education (CPE) activity before accessing the presentation using the link located at the bottom of this page.
ACPE Activity Number: 0204-0000-14-494-H01-P
Release Date: November 12, 2014
Expiration Date: March 2, 2016
Activity Type: Application-based
CE Credits: 1 hour (0.1 CEU), no partial credit
Activity Fee: Free of charge
Accreditation for Pharmacists
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Target Audience
This continuing pharmacy education activity was planned to meet the needs of pharmacists who provide patient care services in hospitals and health systems.
Activity Content
In the United States, acute coronary syndrome (ACS) accounts for more than 1.4 million hospital admissions per year. Between 9% and 19% of persons with ACS die in the first six months after diagnosis. Appropriate management of ACS is essential to optimizing patient outcomes. During this activity, faculty will summarize treatment guidelines for ACS, focusing on antiplatelet therapy. Patient cases will be used to illustrate practical approaches to clinical challenges encountered managing ACS patients throughout the continuum of care, especially during the periprocedural period.
Learning Objectives
At the conclusion of this application-based educational activity, participants should be able to
- Summarize current published treatment guidelines on the management of patients with acute coronary syndrome (ACS), focusing on antiplatelet therapy.
- Evaluate evolving clinical evidence on the use of antiplatelet therapy in the management of ACS and potential impact on recommendations from published treatment guidelines.
- Discuss practical approaches to managing challenges in antiplatelet therapy for ACS patients at different points in the continuum of care.
Faculty
Paul P. Dobesh, Pharm.D., FCCP, BCPS (AQ Cardiology)
Associate Professor of Pharmacy Practice
College of Pharmacy
University of Nebraska Medical Center
Omaha, Nebraska
Paul P. Dobesh, Pharm.D., FCCP, BCPS (AQ Cardiology), is Associate Professor of Pharmacy Practice at the University of Nebraska Medical Center in Omaha, Nebraska. Dr. Dobesh earned both his Bachelor of Science in pharmacy and Doctor of Pharmacy degrees from South Dakota State University. He completed a specialty residency in internal medicine at the University of Texas at Austin at Brackenridge Hospital, and he is a board-certified pharmacotherapy specialist with added qualifications in cardiology.
Dr. Dobesh’s current responsibilities at the University of Nebraska Medical Center (UNMC) include clinical practice in both internal medicine and cardiology services. He is responsible for teaching pharmacy and medical students, as well as pharmacy and medical residents. His main lecture topics include ischemic heart disease, antithrombotic therapy, and other cardiology and critical care topics. Dr. Dobesh received the UNMC College of Pharmacy Distinguished Educator of the Year Award for 2012, an award he has received three times within the last seven years. In 2013, he received the UNMC campus wide Outstanding Educator Award.
Dr. Dobesh has conducted research on antiplatelet and antithrombotic therapy, focusing on the real-world use of these therapies and health-care economics. He has also published book chapters and several manuscripts in this field.
Toby C. Trujillo, Pharm.D., FCCP, FAHA, BCPS (AQ Cardiology)
Associate Professor
Skaggs School of Pharmacy and Pharmaceutical Sciences
University of Colorado Anschutz Medical Campus
Clinical Specialist-Anticoagulation/Cardiology
University of Colorado Hospital
Aurora, Colorado
Toby C. Trujillo, Pharm.D., FCCP, FAHA, BCPS (AQ Cardiology), is Associate Professor of Clinical Pharmacy at Skaggs School of Pharmacy and Pharmaceutical Sciences on the University of Colorado Anschutz Medical Campus in Aurora. He also serves as Clinical Specialist in cardiovascular pharmacotherapy and anticoagulation at University of Colorado Hospital.
Dr. Trujillo earned his Bachelor of Science degree in biochemistry from the University of California, Davis and his Doctor of Pharmacy degree from the University of California, San Francisco, where he also completed a residency in pharmacy practice. Dr. Trujillo completed a fellowship in cardiovascular pharmacotherapy at The University of Arizona, and he is a board-certified pharmacotherapy specialist with added qualifications in cardiology.
Dr. Trujillo’s current responsibilities at University of Colorado Hospital include providing clinical pharmacy services to cardiology, as well as directing the inpatient anticoagulation program. He also serves as co-chair of the anticoagulation subcommittee of the P&T committee. Dr. Trujillo currently serves as a preceptor to both pharmacy students and residents. His lectures at the School of Pharmacy focus on ischemic heart disease, antithrombotic therapy, and other cardiology and critical care topics.
Dr. Trujillo has served in several capacities within the American Heart Association and the Society of Critical Care Medicine. He has also served a number of committees within the American College of Clinical Pharmacy, served as a speaker on numerous occasions on a national level, and authored several articles and book chapters in the area of cardiovascular pharmacotherapy. Dr. Trujillo is a member of the American Society of Health-System Pharmacists, and he helped develop current standards for postgraduate year 2 (PGY2) cardiology residency training programs.
Disclosure Statement
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Guidelines for Standards for Commercial Support, ASHP Advantage requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. A person has a relevant financial relationship if the individual or his or her spouse/partner has a financial relationship (e.g., employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring in the last 12 months with a commercial interest whose products or services may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on presentations.
All faculty and planners for ASHP Advantage education activities are qualified and selected by ASHP Advantage and required to disclose any relevant financial relationships with commercial interests. ASHP Advantage identifies and resolves conflicts of interest prior to an individual’s participation in development of content for an educational activity.
- Paul P. Dobesh, Pharm.D., FCCP, BCPS (AQ Cardiology), declares that he served as a consultant for Astra Zeneca; Bristol-Myers Squibb/Pfizer; Daiichi Sankyo, Inc.; Gilead Sciences, Inc.; and Janssen Pharmaceuticals, Inc.; and also received research grants from AstraZeneca and Daiichi Sankyo, Inc. and Eli Lilly and Company alliance.
- All other faculty and planners report no financial relationships relevant to this activity.
Methods and CE Requirements
This is an online activity consisting of audio and slides, an assessment (post-test), and a course evaluation. Participants should claim continuing education credit for this internet-based educational activity only if they have not claimed credit for the live activity. Participants must view the entire presentation, take the activity assessment (a minimum score of 70% is required), and complete the course evaluation to receive continuing education credit. Follow the prompts at the end of the presentation or click here to claim credit. Credit must be claimed within 60 days of completing the activity. After successfully claiming credit, you may print your statement of credit, and you can return at any time to print a duplicate statement of credit. Please note that for CPE credit, printed statements may not be necessary because your credit will automatically be reported to CPE Monitor.
Agenda
Practical Approaches to Managing Antiplatelet Therapy in Acute Coronary Syndrome
Paul P. Dobesh, Pharm.D., FCCP, BCPS (AQ Cardiology), and Toby C. Trujillo, Pharm.D., FCCP, FAHA, BCPS (AQ Cardiology)
Questions and Answers (optional)
Launch Presentation (60 minutes)**Allow additional time to complete the post-test and evaluation.
Download Assessment and Handout
Print the assessment (post-test) and handout of slides for your reference. Your assessment, however, must be submitted online after you have completed the activity.
Planned and coordinated by ASHP Advantage and supported by an educational grant from The Medicines Company.